TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition.

Persons

Gael McGill

Venue / Journal

Cancer Res

Date

Thu, 02/01/2007 - 12:00

Additional Journal Information

67(3):919-29

Authors

Tsuda M, Davis IJ, Argani P, Shukla N, McGill GG, Nagai M, Saito T, Laé M, Fisher DE, Ladanyi M.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/17283122